Rockland Immunochemcials to Market LIMR's Cell Assays | GenomeWeb

NEW YORK (GenomeWeb News) – Rockland Immunochemicals said today that it will market LIMR Development's cellular assays for research purposes.

The alliance builds on an earlier agreement between Gilbertsville, Pa.-based Rpckland and LIMR, which is a business development subsidiary of the Lankenau Institute for Medical Research.

Under the new agreement, Rockland will sell LIMR's CellCountEZ, OxPhos, RadDose, and Intracellular ThiolEZ assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.